| International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma SV Rajkumar, MA Dimopoulos, A Palumbo, J Blade, G Merlini, MV Mateos, ... The lancet oncology 15 (12), e538-e548, 2014 | 4947 | 2014 |
| International uniform response criteria for multiple myeloma BGM Durie, JL Harousseau, JS Miguel, J Blade, B Barlogie, K Anderson, ... Leukemia 20 (9), 1467-1473, 2006 | 3439 | 2006 |
| A phase 2 study of bortezomib in relapsed, refractory myeloma PG Richardson, B Barlogie, J Berenson, S Singhal, S Jagannath, D Irwin, ... New England Journal of Medicine 348 (26), 2609-2617, 2003 | 3437 | 2003 |
| Review of 1027 patients with newly diagnosed multiple myeloma RA Kyle, MA Gertz, TE Witzig, JA Lust, MQ Lacy, A Dispenzieri, ... Mayo clinic proceedings 78 (1), 21-33, 2003 | 3192 | 2003 |
| Improved survival in multiple myeloma and the impact of novel therapies SK Kumar, SV Rajkumar, A Dispenzieri, MQ Lacy, SR Hayman, FK Buadi, ... Blood, The Journal of the American Society of Hematology 111 (5), 2516-2520, 2008 | 2783 | 2008 |
| International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma S Kumar, B Paiva, KC Anderson, B Durie, O Landgren, P Moreau, ... The lancet oncology 17 (8), e328-e346, 2016 | 2466 | 2016 |
| Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma JF San Miguel, R Schlag, NK Khuageva, MA Dimopoulos, O Shpilberg, ... New England Journal of Medicine 359 (9), 906-917, 2008 | 2453 | 2008 |
| Revised international staging system for multiple myeloma: a report from International Myeloma Working Group A Palumbo, H Avet-Loiseau, S Oliva, HM Lokhorst, H Goldschmidt, ... Journal of clinical oncology 33 (26), 2863, 2015 | 2142 | 2015 |
| A long-term study of prognosis in monoclonal gammopathy of undetermined significance RA Kyle, TM Therneau, SV Rajkumar, JR Offord, DR Larson, MF Plevak, ... New England Journal of Medicine 346 (8), 564-569, 2002 | 1916 | 2002 |
| Initial genome sequencing and analysis of multiple myeloma MA Chapman, MS Lawrence, JJ Keats, K Cibulskis, C Sougnez, ... Nature 471 (7339), 467-472, 2011 | 1688 | 2011 |
| Prevalence of monoclonal gammopathy of undetermined significance RA Kyle, TM Therneau, SV Rajkumar, DR Larson, MF Plevak, JR Offord, ... New England Journal of Medicine 354 (13), 1362-1369, 2006 | 1641 | 2006 |
| Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma RA Kyle, SV Rajkumar Leukemia 23 (1), 3-9, 2009 | 1633 | 2009 |
| Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America DM Weber, C Chen, R Niesvizky, M Wang, A Belch, EA Stadtmauer, ... New England Journal of Medicine 357 (21), 2133-2142, 2007 | 1614 | 2007 |
| Carfilzomib, lenalidomide, and dexamethasone for relapsed multiple myeloma AK Stewart, SV Rajkumar, MA Dimopoulos, T Masszi, I Špička, A Oriol, ... New England Journal of Medicine 372 (2), 142-152, 2015 | 1580 | 2015 |
| Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients SK Kumar, A Dispenzieri, MQ Lacy, MA Gertz, FK Buadi, S Pandey, ... Leukemia 28 (5), 1122-1128, 2014 | 1493 | 2014 |
| The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms R Alaggio, C Amador, I Anagnostopoulos, AD Attygalle, IBO Araujo, ... Leukemia 36 (7), 1720-1748, 2022 | 1467 | 2022 |
| Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study O Landgren, RA Kyle, RM Pfeiffer, JA Katzmann, NE Caporaso, RB Hayes, ... Blood, The Journal of the American Society of Hematology 113 (22), 5412-5417, 2009 | 1376 | 2009 |
| Multiple myeloma: 2020 update on diagnosis, risk‐stratification and management SV Rajkumar American journal of hematology 95 (5), 548-567, 2020 | 1270* | 2020 |
| POEMS syndrome: definitions and long-term outcome: Presented in abstract form at the 41st annual meeting of the American Society of Hematology, New Orleans, LA, December 3-7, 1999. A Dispenzieri, RA Kyle, MQ Lacy, SV Rajkumar, TM Therneau, DR Larson, ... Blood, The Journal of the American Society of Hematology 101 (7), 2496-2506, 2003 | 1197 | 2003 |
| Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised … SV Rajkumar, S Jacobus, NS Callander, R Fonseca, DH Vesole, ... The lancet oncology 11 (1), 29-37, 2010 | 1192 | 2010 |
Rafael Fonseca M.D.Mayo Clinic in Arizona, Professor of Medicine在 mayo.edu 的電子郵件地址已通過驗證
